Gastroenterology
Latest News
May 29th 2025
Your daily dose of the clinical news you may have missed.
Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®
View More
10th Annual School of Gastrointestinal Oncology
View More
BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC
View More
Community Practice Connections™: 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
View More
Go To PER in Chicago
May 30, 2025 - June 3, 2025
Register Now!
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management
View More
Burst CME™: Future Implications for the Treatment Landscape of Primary Biliary Cholangitis (PBC)
View More
Burst CME™: Reimagining Approaches to Treating Patients with Primary Biliary Cholangitis (PBC)
View More
Burst CME™: Enhancing Strategies for Diagnosing Primary Biliary Cholangitis (PBC)
View More
Medical Crossfire: Individualizing Treatment Plans in Advanced Hepatocellular Carcinoma Based on Biology and Other Patient Characteristics
View More
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting
View More
Community Practice Connections™: Individualizing Treatment Plans in Advanced Hepatocellular Carcinoma Based on Biology and Other Patient Characteristics
View More
Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?
View More
(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention
View More
(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention
View More
Community Practice Connections™: 21st Annual Meeting of the International Society of Gastrointestinal Oncology
View More
42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow
View More
Molecular Testing and Personalized Strategies in Pancreatic Cancer: Targeting NRG1 and Rare Drivers With an Optimized Approach
View More
Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers
View More
More News
Irritable Bowel Syndrome: Rational Therapy
January 1st 2007ABSTRACT: Irritable bowel syndrome (IBS) is characterized by abdominal pain or discomfort, bloating, and constipation or diarrhea; the pain is typically relieved by defecation. The diagnosis is not one of exclusion; it can be made based on the answers to a few key questions and the absence of "alarm" symptoms. Fiber therapy, the elimination of particular foods, and regulation of bowel function can help relieve symptoms. Tegaserod or polyethylene glycol can be used to treat IBS with constipation. Loperamide and alosetron are of benefit in IBS with diarrhea (although the latter carries a small risk of ischemic colitis). Low-dose tricyclic antidepressants may be used to treat the abdominal pain associated with IBS. Probiotic therapy or rifaximin may help reduce bloating. Psychological therapies seem to improve well-being in patients with IBS.
